Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
374
1
30

Year Published

2017
2017
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 432 publications
(413 citation statements)
references
References 226 publications
8
374
1
30
Order By: Relevance
“…At the time we applied for the BNHI database, only data for years 1996 to 2008 were available, so year 2008 was the last year we could use to analyze the initial OAD used in new diabetes patients, and we were unable to observe the impact of the ADA/EASD guidelines published in 2009. GLP-1 receptor agonists and Sodium glucose cotransporter 2 (SGLT-2) inhibitors are two types of new T2D Pharmacotherapy [13]. Although they are used for diabetes treatment for several years around the world, we are unable the check their usage due to the BNHI database which we applied is year [2004][2005][2006][2007][2008].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…At the time we applied for the BNHI database, only data for years 1996 to 2008 were available, so year 2008 was the last year we could use to analyze the initial OAD used in new diabetes patients, and we were unable to observe the impact of the ADA/EASD guidelines published in 2009. GLP-1 receptor agonists and Sodium glucose cotransporter 2 (SGLT-2) inhibitors are two types of new T2D Pharmacotherapy [13]. Although they are used for diabetes treatment for several years around the world, we are unable the check their usage due to the BNHI database which we applied is year [2004][2005][2006][2007][2008].…”
Section: Discussionmentioning
confidence: 99%
“…The American Diabetes Association and the European Association for the Study of Diabetes (ADA/EASD) have released a consensus algorithm for the initial management and the adjustment of therapy, as a guide to the treatment of type 2 diabetes [11][12][13]. The algorithm describes a stepped-care approach to treat the elevated levels of blood glucose and HbA1C.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 However, this consensus statement was written to reflect the various aspects of pre-diabetes management from an Asian perspective. Majority of the consensus statements were crafted based on studies conducted in Western populations without consideration of the cultural nuances that are sensitive and specific to Asian populations.…”
Section: Methodsmentioning
confidence: 99%
“…The AACE diabetes guidelines suggest that non-HDL-C goal is to be achieved with TG lowering therapy after achievement of desirable LDL-C level. 16 Recent lipid guidelines by Lipid Association of India (LAI) have also recommended use of non-statin therapy when serum TG levels remain persistently elevated (>200 mg/ dL) despite optimum dose of statins. 17 Very recently published European Society of Cardiology (ESC) guidelines on dyslipidemia suggest that non-fasting TGs may carry information regarding remnant lipoproteins associated with increased risk.…”
Section: Hypertriglyceridemia As a Cvd Risk Factormentioning
confidence: 99%